Patents by Inventor Yosuke Ogoshi

Yosuke Ogoshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TETRAHYDROBENZOFURODIAZEPINONE COMPOUND AND PHARMACEUTICAL USE THEREOF
    Publication number: 20240116943
    Abstract: The present invention provides a compound having a Pim-1 inhibitory activity. The present invention provides a compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the same, and a pharmaceutical use thereof, and the like. wherein each symbol is as defined in the description.
    Type: Application
    Filed: March 21, 2023
    Publication date: April 11, 2024
    Inventors: Masafumi Inoue, Yosuke Ogoshi, Takayuki Furukawa, Takuya Machida, Ikuo Mitani, Kazuhito Harada, Yuichi Nakagawa, Nobutaka Yamaoka
  • DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
    Publication number: 20230373932
    Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.
    Type: Application
    Filed: December 20, 2022
    Publication date: November 23, 2023
    Inventors: Masahiro YOKOTA, Taku IKENOGAMI, Eiichi WATANABE, Noriyoshi SEKI, Takayuki SAKAI, Shingo FUJIOKA, Makoto SHIOZAKI, Katsunori SUWA, Yosuke OGOSHI, Masato NOGUCHI, Katsuya MAEDA
  • PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
    Publication number: 20230348438
    Abstract: A compound of the following general Formula [Ib]: wherein each symbol is the same as defined in the description; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 2, 2022
    Publication date: November 2, 2023
    Inventors: Tomoya MIURA, Yosuke Ogoshi, Kazuhito Ueyama, Dai Motoda, Toshihiko Iwayama, Koichi Suzawa, Hironobu Nagamori, Hiroshi Ueno, Akihiko Takahashi, Kazuyuki Sugimoto
  • Tetrahydrobenzofurodiazepinone compound and pharmaceutical use thereof
    Patent number: 11643417
    Abstract: The present invention provides a compound having a Pim-1 inhibitory activity. The present invention provides a compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the same, and a pharmaceutical use thereof, and the like. wherein each symbol is as defined in the description.
    Type: Grant
    Filed: October 4, 2021
    Date of Patent: May 9, 2023
    Assignee: Japan Tobacco Inc.
    Inventors: Masafumi Inoue, Yosuke Ogoshi, Takayuki Furukawa, Takuya Machida, Ikuo Mitani, Kazuhito Harada, Yuichi Nakagawa, Nobutaka Yamaoka
  • TETRAHYDROBENZOFURODIAZEPINONE COMPOUND AND PHARMACEUTICAL USE THEREOF
    Publication number: 20220162220
    Abstract: The present invention provides a compound having a Pim-1 inhibitory activity. The present invention provides a compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the same, and a pharmaceutical use thereof, and the like. wherein each symbol is as defined in the description.
    Type: Application
    Filed: October 4, 2021
    Publication date: May 26, 2022
    Applicant: Japan Tobacco Inc.
    Inventors: Masafumi Inoue, Yosuke Ogoshi, Takayuki Furukawa, Takuya Machida, Ikuo Mitani, Kazuhito Harada, Yuichi Nakagawa, Nobutaka YAMAOKA
  • DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
    Publication number: 20210130300
    Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.
    Type: Application
    Filed: June 16, 2020
    Publication date: May 6, 2021
    Inventors: Masahiro YOKOTA, Taku IKENOGAMI, Eiichi WATANABE, Noriyoshi SEKI, Takayuki SAKAI, Shingo FUJIOKA, Makoto SHIOZAKI, Katsunori SUWA, Yosuke OGOSHI, Masato NOGUCHI, Katsuya MAEDA
  • PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
    Publication number: 20200317644
    Abstract: A compound of the following general Formula [Ib]: wherein each symbol is the same as defined in the description; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 7, 2019
    Publication date: October 8, 2020
    Inventors: Tomoya MIURA, Yosuke OGOSHI, Kazuhito UEYAMA, Dai MOTODA, Toshihiko IWAYAMA, Koichi SUZAWA, Hironobu NAGAMORI, Hiroshi UENO, Akihiko TAKAHASHI, Kazuyuki SUGIMOTO
  • TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT
    Publication number: 20200017492
    Abstract: The present invention provides a triazolopyridine compound having a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability. The present invention relates to a compound represented by the following formula [I]: wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof, as well as a prolyl hydroxylase inhibitor or erythropoietin production-inducing agent containing the compound. The compound of the present invention shows a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability and is useful as a prophylactic or therapeutic agent for various diseases and pathologies (disorders) caused by decreased production of erythropoietin.
    Type: Application
    Filed: September 4, 2019
    Publication date: January 16, 2020
    Inventors: Ikuo Mitani, Yosuke Ogoshi, Takuya Matsui, Masahiro Yokota, Masakazu Terashita, Dai Motoda, Kazuhito Ueyama, Hiroyuki Abe, Takahiro Hotta, Takashi Ito
  • DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
    Publication number: 20190359575
    Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.
    Type: Application
    Filed: December 20, 2018
    Publication date: November 28, 2019
    Inventors: Masahiro YOKOTA, Taku IKENOGAMI, Eiichi WATANABE, Noriyoshi SEKI, Takayuki SAKAI, Shingo FUJIOKA, Makoto SHIOZAKI, Katsunori SUWA, Yosuke OGOSHI, Masato NOGUCHI, Katsuya MAEDA
  • PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
    Publication number: 20180346449
    Abstract: A compound of the following general Formula [Ib]: wherein each symbol is the same as defined in the description; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 21, 2017
    Publication date: December 6, 2018
    Inventors: Tomoya MIURA, Yosuke OGOSHI, Kazuhito UEYAMA, Dai MOTODA, Toshihiko IWAYAMA, Koichi SUZAWA, Hironobu NAGAMORI, Hiroshi UENO, Akihiko TAKAHASHI, Kazuyuki SUGIMOTO
  • DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
    Publication number: 20160194290
    Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.
    Type: Application
    Filed: December 11, 2015
    Publication date: July 7, 2016
    Inventors: Masahiro YOKOTA, Taku IKENOGAMI, Eiichi WATANABE, Noriyoshi SEKI, Takayuki SAKAI, Shingo FUJIOKA, Makoto SHIOZAKI, Katsunori SUWA, Yosuke OGOSHI, Masato NOGUCHI, Katsuya MAEDA
  • TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT
    Publication number: 20160145254
    Abstract: The present invention provides a triazolopyridine compound having a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability. The present invention relates to a compound represented by the following formula [I]: wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof, as well as a prolyl hydroxylase inhibitor or erythropoietin production-inducing agent containing the compound. The compound of the present invention shows a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability and is useful as a prophylactic or therapeutic agent for various diseases and pathologies (disorders) caused by decreased production of erythropoietin.
    Type: Application
    Filed: June 25, 2015
    Publication date: May 26, 2016
    Inventors: Ikuo Mitani, Yosuke Ogoshi, Takuya Matsui, Masahiro Yokota, Masakazu Terashita, Dai Motoda, Kazuhito Ueyama, Hiroyuki Abe, Takahiro Hotta, Takashi Ito
  • PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
    Publication number: 20150183763
    Abstract: The present invention provides a pyrazole compound of the following general Formula [Ib] having SGLT1 inhibitory activity, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and its pharmaceutical use: wherein each symbol is the same as defined in the description.
    Type: Application
    Filed: July 29, 2014
    Publication date: July 2, 2015
    Inventors: Tomoya MIURA, Yosuke OGOSHI, Kazuhito UEYAMA, Dai MOTODA, Toshihiko IWAYAMA, Koichi SUZAWA, Hironobu NAGAMORI, Hiroshi UENO, Akihiko TAKAHASHI, Kazuyuki SUGIMOTO
  • Pyrazole compound and pharmaceutical use thereof
    Patent number: 8846746
    Abstract: The present invention provides a pyrazole compound of the following general Formula [Ib] having SGLT1 inhibitory activity, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and its pharmaceutical use: wherein each symbol is the same as defined in the description.
    Type: Grant
    Filed: August 30, 2012
    Date of Patent: September 30, 2014
    Assignee: Japan Tobacco Inc.
    Inventors: Tomoya Miura, Yosuke Ogoshi, Kazuhito Ueyama, Dai Motoda, Toshihiko Iwayama, Koichi Suzawa, Hironobu Nagamori, Hiroshi Ueno, Akihiko Takahashi, Kazuyuki Sugimoto
  • TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT
    Publication number: 20130096155
    Abstract: The present invention provides a triazolopyridine compound having a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability. The present invention relates to a compound represented by the following formula [I]: wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof, as well as a prolyl hydroxylase inhibitor or erythropoietin production-inducing agent containing the compound. The compound of the present invention shows a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability and is useful as a prophylactic or therapeutic agent for various diseases and pathologies (disorders) caused by decreased production of erythropoietin.
    Type: Application
    Filed: September 6, 2012
    Publication date: April 18, 2013
    Applicant: JAPAN TOBACCO INC.
    Inventors: Ikuo Mitani, Yosuke Ogoshi, Takuya Matsui, Masahiro Yokota, Masakazu Terashita, Dai Motoda, Kazuhito Ueyama, Hiroyuki Abe, Takahiro Hotta, Takashi Ito
  • PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
    Publication number: 20130085132
    Abstract: The present invention provides a pyrazole compound of the following general Formula [Ib] having SGLT1 inhibitory activity, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and its pharmaceutical use: wherein each symbol is the same as defined in the description.
    Type: Application
    Filed: August 30, 2012
    Publication date: April 4, 2013
    Applicant: JAPAN TOBACCO INC.
    Inventors: Tomoya MIURA, Yosuke OGOSHI, Kazuhito UEYAMA, Dai MOTODA, Toshihiko IWAYAMA, Koichi SUZAWA, Hironobu NAGAMORI, Hiroshi UENO, Akihiko TAKAHASHI, Kazuyuki SUGIMOTO
  • Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent
    Patent number: 8283465
    Abstract: The present invention provides a triazolopyridine compound having a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability. The present invention relates to a compound represented by the following formula [I]: wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof, as well as a prolyl hydroxylase inhibitor or erythropoietin production-inducing agent containing the compound. The compound of the present invention shows a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability and is useful as a prophylactic or therapeutic agent for various diseases and pathologies (disorders) caused by decreased production of erythropoietin.
    Type: Grant
    Filed: July 16, 2010
    Date of Patent: October 9, 2012
    Assignee: Japan Tobacco Inc.
    Inventors: Ikuo Mitani, Yosuke Ogoshi, Takuya Matsui, Masahiro Yokota, Masakazu Terashita, Dai Motoda, Kazuhito Ueyama, Hiroyuki Abe, Takahiro Hotta, Takashi Ito
  • TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT
    Publication number: 20110077267
    Abstract: The present invention provides a triazolopyridine compound having a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability. The present invention relates to a compound represented by the following formula [I]: wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof, as well as a prolyl hydroxylase inhibitor or erythropoietin production-inducing agent containing the compound. The compound of the present invention shows a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability and is useful as a prophylactic or therapeutic agent for various diseases and pathologies (disorders) caused by decreased production of erythropoietin.
    Type: Application
    Filed: July 16, 2010
    Publication date: March 31, 2011
    Applicant: JAPAN TOBACCO INC.
    Inventors: Ikuo Mitani, Yosuke Ogoshi, Takuya Matsui, Masahiro Yokota, Masakazu Terashita, Dai Motoda, Kazuhito Ueyama, Hiroyuki Abe, Takahiro Hotta, Takashi Ito